These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 19797255

  • 1. Arrhythmic death in implantable cardioverter defibrillator patients: a long-term study over a 10 year implantation period.
    Duray GZ, Schmitt J, Richter S, Israel CW, Hohnloser SH.
    Europace; 2009 Nov; 11(11):1462-8. PubMed ID: 19797255
    [Abstract] [Full Text] [Related]

  • 2. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
    Healey JS, Hallstrom AP, Kuck KH, Nair G, Schron EP, Roberts RS, Morillo CA, Connolly SJ.
    Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
    [Abstract] [Full Text] [Related]

  • 3. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
    Stockburger M, Krebs A, Nitardy A, Habedank D, Celebi O, Knaus T, Dietz R.
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
    [Abstract] [Full Text] [Related]

  • 4. Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators.
    Kolb C, Deisenhofer I, Schmieder S, Barthel P, Zrenner B, Karch MR, Schmitt C.
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):946-52. PubMed ID: 16981917
    [Abstract] [Full Text] [Related]

  • 5. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD, Burke MC, Hong TE, Kim S, Salem Y, Yong PG, Knight BP.
    J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
    [Abstract] [Full Text] [Related]

  • 6. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
    Chen HA, Hsia HH, Vagelos R, Fowler M, Wang P, Al-Ahmad A.
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):390-4. PubMed ID: 17367359
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
    Marijon E, Trinquart L, Otmani A, Waintraub X, Kacet S, Clémenty J, Chatellier G, Le Heuzey JY, Evaluation Médico-Economique du Défibrillateur Automatique Implantable (EVADEF) Investigators.
    Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
    [Abstract] [Full Text] [Related]

  • 9. Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis.
    Korantzopoulos P, Liu T, Li L, Goudevenos JA, Li G.
    Europace; 2009 Nov; 11(11):1469-75. PubMed ID: 19812050
    [Abstract] [Full Text] [Related]

  • 10. Impact of renal dysfunction on appropriate therapy in implantable cardioverter defibrillator patients with non-ischaemic dilated cardiomyopathy.
    Takahashi A, Shiga T, Shoda M, Manaka T, Ejima K, Hagiwara N.
    Europace; 2009 Nov; 11(11):1476-82. PubMed ID: 19661116
    [Abstract] [Full Text] [Related]

  • 11. Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing.
    Stockburger M, Celebi O, Krebs A, Knaus T, Nitardy A, Habedank D, Dietz R.
    Europace; 2009 Jul; 11(7):924-30. PubMed ID: 19447808
    [Abstract] [Full Text] [Related]

  • 12. Clustering of ventricular tachyarrhythmias in heart failure patients implanted with a biventricular cardioverter defibrillator.
    Lunati M, Gasparini M, Bocchiardo M, Curnis A, Landolina M, Carboni A, Luzzi G, Zanotto G, Ravazzi P, Magenta G, Denaro A, Distefano P, Grammatico A, InSync ICD Italian Registry Investigators.
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1299-306. PubMed ID: 17239095
    [Abstract] [Full Text] [Related]

  • 13. Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study.
    Albert CM, Rosenthal L, Calkins H, Steinberg JS, Ruskin JN, Wang P, Muller JE, Mittleman MA, TOVA Investigators.
    J Am Coll Cardiol; 2007 Dec 04; 50(23):2233-40. PubMed ID: 18061071
    [Abstract] [Full Text] [Related]

  • 14. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
    Zareba W, Piotrowicz K, McNitt S, Moss AJ, MADIT II Investigators.
    Am J Cardiol; 2005 Jun 15; 95(12):1487-91. PubMed ID: 15950580
    [Abstract] [Full Text] [Related]

  • 15. Effect of elapsed time from coronary revascularization to implantation of a cardioverter defibrillator on long-term survival in the MADIT-II trial.
    Barsheshet A, Goldenberg I, Moss AJ, Huang DT, Zareba W, McNitt S, Klein HU, Guetta V.
    J Cardiovasc Electrophysiol; 2011 Nov 15; 22(11):1237-42. PubMed ID: 21615813
    [Abstract] [Full Text] [Related]

  • 16. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.
    Elliott PM, Gimeno JR, Tomé MT, Shah J, Ward D, Thaman R, Mogensen J, McKenna WJ.
    Eur Heart J; 2006 Aug 15; 27(16):1933-41. PubMed ID: 16754630
    [Abstract] [Full Text] [Related]

  • 17. Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period.
    Trappe HJ, Pfitzner P, Achtelik M, Fieguth HG.
    Heart; 1997 Oct 15; 78(4):364-70. PubMed ID: 9404252
    [Abstract] [Full Text] [Related]

  • 18. Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients.
    Hreybe H, Razak E, Saba S.
    Pacing Clin Electrophysiol; 2007 Sep 15; 30(9):1091-5. PubMed ID: 17725751
    [Abstract] [Full Text] [Related]

  • 19. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.
    Cuculich PS, Sánchez JM, Kerzner R, Greenberg SL, Sengupta J, Chen J, Faddis MN, Gleva MJ, Smith TW, Lindsay BD.
    Pacing Clin Electrophysiol; 2007 Feb 15; 30(2):207-13. PubMed ID: 17338717
    [Abstract] [Full Text] [Related]

  • 20. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial.
    Almendral J, Arribas F, Wolpert C, Ricci R, Adragao P, Cobo E, Navarro X, Quesada A, DATAS Steering Committee, DATAS Writing Committee, DATAS Investigators.
    Europace; 2008 May 15; 10(5):528-35. PubMed ID: 18390985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.